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ABSTRACT
Vaccines are weakened or dead microbes injected for the development of an acquired immunity as a preventive measure, also including the use of 
microbial proteins. The spectrum of adverse events following vaccination has been increasing as well with increasing number of reports detailing the 
events following immunization. The rate of morbidity and mortality of many communicable diseases has significantly decreased with time with relieve 
to the quality of life as well as the overall pharma economic cost. In this case report vaccine-induced developmental delay was observed in a child of 
16 months of age. The child was born with low birth weight despite which the child was administered with hepatitis B vaccine, poliomyelitis vaccine, and 
bacillus Calmette-Guerin within 24 h of birth. Consecutive clinical outcomes followed throughout the years, which induced a developmental delay in this 
child. This case clearly signifies the need for more evidence-based implementation for the management of various diseases at secondary care hospitals.
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INTRODUCTION
An adverse drug event can be defined as an injury occurring resultant 
to a drug. In addition, it includes medication errors, adverse drug 
reactions, allergic reactions, and overdoses [1,2]. Vaccine-induced 
adverse events usually constitute of anaphylactic reactions and most 
commonly fever which may result into febrile seizures [3].
A febrile seizure can be defined as a seizure associated with fever 
resultant above 100.4oF. The prevalence is higher in children aged 
between 6 months and 5 years, with most of the seizures occurring 
between 14 and 18 months of age [4]. Recent evidence suggests an 
increased risk for febrile seizures after vaccinations such as mumps 
measles rubella and mumps measles rubella varicella and hepatitis B 
vaccine (HBV) [5]. Usually, febrile seizures resolve once the child reaches 
the age of 6 years. However, in subjects with positive family history, they 
may go on to have febrile seizures well beyond this age, even into adult 
life. This may not necessarily be associated with high temperature, 
leading to generalized tonic-clonic seizures [4]. A generalized tonic-
clonic seizure may attribute for further neurological damage usually 
affecting the entire brain [6]. The etiologies and pathophysiology may 
vary depending on the patient and the risk factors (head trauma, central 
nervous system infections, febrile seizures, developmental history, and 
medications/toxin exposures) [7]. Recent studies reported that genetic 
or structural defects are the underlying causes of seizures, which may 
be activated after vaccination presumably due to the interplay of the 
innate biology of the body [8].
The latest trends in vaccine safety include that of world health 
organization. Adverse events following immunization (AEFI) is 
classified into four categories, namely program-related, vaccine-
induced, coincidental, and unknown, where program-related AEFI 
attribute mostly to the errors in the vaccine itself, dosage forms, and 
route of administration. Vaccine induced AEFI occurs due to either 
the effects of vaccine or one of its components or may be due some 
underlying medical conditions or because of an idiosyncratic reaction.
Anaphylaxis reactions are rare, and the onset of anaphylaxis may occur 
within minutes with an unpredictable clinical course [9]. In this case 
report, we present a vaccine-induced developmental delay.
CASE REPORT
A 2-years-old male child presented with complaints of cough since 2 
days, and with a history of breathing difficulty. The child weighed about 
10 kg and while on examination, the vitals are pulse rate at 116 beats 
per min, respiratory rate at 36 per min. He was found to be afebrile and 
cardiovascular system with S1 and S2 +, with positive bilateral air entry, 
however, with bilateral crept being present in the respiratory system. 
The child was diagnosed as wheeze associated with lower respiratory 
tract infection.
On assessing the medical history of the patient, the child was normally 
delivered with no defects and with no history of familial deformities.
The patient was found to be a known case of generalized tonic-clonic 
seizures, delayed development and wheeze associated with lower 
respiratory tract infection was diagnosed since the past 2 weeks. 
He was treated with injection ampicillin 250 mg intravenous twice 
daily, injection gentamicin 20 mg Intravenous twice daily, syrup 
paracetamol 50 ml (25 mg/ml), tablet salbutamol ¼ of 4 mg 3 times a 
day, salbutamol nebulization 3 times a day, and tablet chlorpheniramine 
maleate ¼–0-¼ and was discharged with tablet amoxicillin 125 mg 
3 times a day for 7 days, tablet zinc ½ (10 mg) once daily for 5 days 
followed by tablet chlorpheniramine maleate 1 mg twice daily for 3 days.
Assessing further history, it was noted that the child was given HBV, 
poliomyelitis vaccine (PMV), and bacillus Calmette-Guerin (BCG) 
within 12 h of birth following which the child developed fever, which 
was symptomatically controlled. For this, the child got admitted in the 
neonatal intensive care unit where he developed febrile seizure and 
was prescribed with tablet sodium valproate 200 mg once daily and 
tablet clonazepam 0.25 mg twice daily.
At present, the child was found to be afebrile, yet irritable. He was 
well hydrated, and despite normal cardiovascular sounds, creps were 
positive for the respiratory system. Respiratory rate was found at 48 
beats/min with 84% SpO2 in room air. On the physical assessments, it 
was quite evident that the child has a developmental delay. He was not 
able to utter words and not even able to walk like other children of his 
age.
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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The laboratory results suggested anemia with hemoglobin 9.7 g/dL, 
hematocrit 31.2%, mean cell volume 64.9 m3, and mean cell hemoglobin 
at 20.2 pg/cell. The total count was also elevated at 12.8×103 cells/mm3, 
which indicates infection. The treatment given was as follows, oxygen 
through face mask at the rate of 5 L/min, injection hydrocortisone 
50 mg intravenous twice daily, salbutamol nebulizer for 20 min 3 times 
a day, injection cefotaxime 500 mg intravenous 3 times a day, injection 
ranitidine 10 mg intravenous twice daily, tablet sodium valproate 
200 mg once daily, and tablet clonazepam 0.25 mg twice daily.
On the 2nd day, bilateral creps were positive, with pulse rate at 122 
beats/min, respiratory rate at 30 beats/min and 89% SpO2. Treatment 
was followed as injection hydrocortisone 50 mg intravenous twice daily, 
salbutamol nebulizer Q8H, injection cefotaxime 500 mg intravenous 
thrice daily, injection ranitidine 10 mg intravenous twice daily, tablet 
sodium valproate 200 mg once daily, and tablet clonazepam 0.25 mg 
twice daily. On the 3rd day, the patient presented with complaints of a 
cough. Injection hydrocortisone was stopped and followed by adding 
tablet prednisolone 5 mg and tablet azithromycin 250 mg ½ once 
daily to the therapy. The patient was discharged on the 4th day with 
tablet sodium valproate 200 mg once daily, tablet clonazepam 0.25 mg 
twice daily, tablet azithromycin 250 mg ½ once daily for 4 days, tablet 
cetirizine 5 mg ½ at night time for 4 days, tablet salbutamol ½ at 
hour of sleep for 4 days, and Budecort 100 mcg 1 puff twice daily for 
3 months.
DISCUSSION
With an increasing number of infectious diseases as well as resistant 
strains, the need for a preventive strategy is a must [10]. However, 
apart from these active constituents, the vaccine contains one or more 
of excipients, and once the vaccine enters one’s fluid system, a cascade 
of immunological responses takes place. This pathway defines ones 
intrinsic reactions to the vaccine for the outcome of a proper response 
or an anaphylactic reaction [11].
In this case report, the patient despite with low birth weight was given 
BCG, oral polio vaccine, and HBV within 24 h of birth. A question that 
arises now is the ultimate fate of the immune system and the biological 
pathways in low birth weight children. The excipients content of the 
HBV was aluminum hydroxide gel 0.25 mg, thiomersal 0.025 mg, and 
phosphate buffer. BCG vaccine being constituted in sodium chloride 1 ml 
0.9% w/v and PMV contains kanamycin 20 mcg as a preservative. This 
brings to light the thiomersal controversy, the removal of thiomersal 
from vaccines in the United States of America since 2001. Where, 
once evidence suggested the association between thiomersal and 
autism while some of the other evidence not supporting the same [12]. 
However, considering the risk verses benefit, ensuring thiomersal is 
really associated or not associated to neurological deformities is still 
controversial. Further requires more evidences and justification.
Furthermore, current recommendations state the need for scheduled 
vaccinations in preterm and children born with low birth weight [13]. 
However, this recommendation is feasible only if the child is clinically 
stable. Quite contrarily, the debate lies in the doses of the vaccine given 
at the time of birth, that is, HBV and BCG. Still, the implementation of 
these is restricted in most countries due to the concerns of parents and 
the health-care providers regarding the biology of immunogenicity 
and safety of vaccines in these populations [14]. However, the 
conclusiveness of these finding is a big question keeping in mind 
the scarcity of evidence in this field. In this case report, the child 
despite born with low birth weight was given three vaccinations as 
mentioned above and sequentially developed fever post-vaccination 
resultant into a febrile seizure. Recurrent febrile seizures led to 
generalized tonic-clonic seizures not associated with fever. The child 
suffers from the developmental delay at present. Recent data suggest 
the interplay of plasma multiplex cytokines and increased level of 
interleukin-10 and interleukin-1 receptor antagonist as an etiological 
factor for conversion of febrile seizures into non-febrile seizure [15].
The laboratory values indicated a decreased value of hemoglobin, 
hematocrit, mean cell volume, mean cell hemoglobin, and a increased 
value in total white cell count. The treatment that followed indicated 
for supportive and symptomatic relief. Preventive therapy was 
initiated later only with an inhaled corticosteroid. Irrational use of 
antibiotics and corticosteroids was observed in this case, however, with 
guidelines suggesting antibiotic therapy first-line therapy being the 
macrolides or amoxicillin followed by preventive measure with inhaled 
corticosteroids [16].
The long-term use of sodium valproate carries an enormous risk of 
hepatotoxicity; however, no laboratory tests were done regarding 
the hepatic abnormality and the laboratory test done was yet not 
sufficient to rule out many of the complications. In such cases, there 
is an enormous need of diagnostic protocols [17]. However, in this 
present scenario, prolonged therapy with sodium valproate yielded 
acceptable outcome, though the use of add-on therapy with clonazepam 
indicates the lack of guideline implementation. Laboratory findings and 
interpretations are necessary in such cases to rule out any forms of 
complications that need to be addressed.
In addition, it was quite evident the child had a developmental delay 
(Fig. 1). Developmental delays and autism can be a consequence of 
vaccine-induced adverse events where the developmental delay is 
a neurological disorder with huge impact on the quality of life of the 
patient [18]. Furthermore, the possible association between vaccination 
and developmental disorders has been subject of great debate resultant 
doubts and anxiety in the parents seeking the best for their child [19].
This case clearly demonstrates the lack of guideline implementation 
in the management of respiratory and neurological diseases and 
furthermore the scarcity of evidence in the sequential vaccination in 
low birth weight child.
CONCLUSION
This case clearly signifies the need for more evidence-based 
implementation for the management of various diseases at secondary 
level hospitals. In addition, further studies are needed to demonstrate 
the impact of vaccination schedules based on the birth weight of 
the child and whether thiomersal-containing vaccines should be 
administered or not. Conclusive guidelines and updated knowledge for 
physicians are a need of the hour, resultant less incidences of health 
burden to the general population.
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